Dapagliflozin in Patients Hospitalized for Heart Failure: Primary Results of the DAPA ACT HF-TIMI 68 Randomized Clinical Trial and Meta-Analysis of Sodium-Glucose Cotransporter-2 Inhibitors in Patients Hospitalized for Heart Failure.

Berg DD, Patel SM, Haller PM, Cange AL, Palazzolo MG, Bellavia A, Kuder JF, Desai AS, Inzucchi SE, McMurray JJV, O'Meara E, Verma S, Bělohlávek J, Drożdż J, Merkely B, Ogunniyi MO, Drasnar T, Izzo JL, Sarman B, McGinty JE, Ramanathan K, Mulkay AJ, Przybylski A, Ruff CT, O'Donoghue ML, Murphy SA, Sabatine MS, Wiviott SD, DAPA ACT HF-TIMI 68 Trial Committees and Investigators.

Open source

DOI: 10.1161/circulationaha.125.076575
Published: 2025-08-29
Container: Circulation
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1161/circulationaha.125.076575,
  title = {Dapagliflozin in Patients Hospitalized for Heart Failure: Primary Results of the DAPA ACT HF-TIMI 68 Randomized Clinical Trial and Meta-Analysis of Sodium-Glucose Cotransporter-2 Inhibitors in Patients Hospitalized for Heart Failure.},
  author = {Berg DD and  Patel SM and  Haller PM and  Cange AL and  Palazzolo MG and  Bellavia A and  Kuder JF and  Desai AS and  Inzucchi SE and  McMurray JJV and  O'Meara E and  Verma S and  Bělohlávek J and  Drożdż J and  Merkely B and  Ogunniyi MO and  Drasnar T and  Izzo JL and  Sarman B and  McGinty JE and  Ramanathan K and  Mulkay AJ and  Przybylski A and  Ruff CT and  O'Donoghue ML and  Murphy SA and  Sabatine MS and  Wiviott SD and  DAPA ACT HF-TIMI 68 Trial Committees and Investigators.},
  year = {2025},
  journal = {Circulation},
  doi = {10.1161/circulationaha.125.076575},
  url = {https://doi.org/10.1161/circulationaha.125.076575}
}

RIS

TY  - JOUR
TI  - Dapagliflozin in Patients Hospitalized for Heart Failure: Primary Results of the DAPA ACT HF-TIMI 68 Randomized Clinical Trial and Meta-Analysis of Sodium-Glucose Cotransporter-2 Inhibitors in Patients Hospitalized for Heart Failure.
AU  - Berg DD
AU  -  Patel SM
AU  -  Haller PM
AU  -  Cange AL
AU  -  Palazzolo MG
AU  -  Bellavia A
AU  -  Kuder JF
AU  -  Desai AS
AU  -  Inzucchi SE
AU  -  McMurray JJV
AU  -  O'Meara E
AU  -  Verma S
AU  -  Bělohlávek J
AU  -  Drożdż J
AU  -  Merkely B
AU  -  Ogunniyi MO
AU  -  Drasnar T
AU  -  Izzo JL
AU  -  Sarman B
AU  -  McGinty JE
AU  -  Ramanathan K
AU  -  Mulkay AJ
AU  -  Przybylski A
AU  -  Ruff CT
AU  -  O'Donoghue ML
AU  -  Murphy SA
AU  -  Sabatine MS
AU  -  Wiviott SD
AU  -  DAPA ACT HF-TIMI 68 Trial Committees and Investigators.
PY  - 2025
JO  - Circulation
DO  - 10.1161/circulationaha.125.076575
UR  - https://doi.org/10.1161/circulationaha.125.076575
ER  -

APA

DD, B., SM, P., PM, H., AL, C., MG, P., A, B., JF, K., AS, D., SE, I., JJV, M., E, O., S, V., J, B., J, D., B, M., MO, O., T, D., JL, I., B, S., JE, M., K, R., AJ, M., A, P., CT, R., ML, O., SA, M., MS, S., SD, W., & Investigators., D. A. H. 6. T. C. A. (2025). Dapagliflozin in Patients Hospitalized for Heart Failure: Primary Results of the DAPA ACT HF-TIMI 68 Randomized Clinical Trial and Meta-Analysis of Sodium-Glucose Cotransporter-2 Inhibitors in Patients Hospitalized for Heart Failure.. Circulation. https://doi.org/10.1161/circulationaha.125.076575

Source records

europe-pmc · retrieved 2026-09-25T21:15:15.944Z